-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Underweight on Integra Lifesciences, Lowers Price Target to $14

Benzinga·10/22/2026 14:01:05
JP Morgan analyst Robbie Marcus maintains Integra Lifesciences (NASDAQ:IART) with a Underweight and lowers the price target from $17 to $14.